Panacea Biotec

• 

  Panacea Biotec Rallies 9% On Receiving License To Produce Sputnik V Vaccine

  The Sputnik V vaccine will be produced at Panacea Biotec's Baddi manufacturing facility in Himachal Pradesh.

• 

  Stocks To Watch: Tata Steel, Panacea Biotec, Federal Bank

  Tata Steel's India crude steel production in Q1FY22 fell 2.7 per cent compared to 4.62 million tonnes in the same quarter last year

• 

  Someone From Russia Found Vaccine Maker In Himachal, Centre Failed: High Court

  Delhi High Court expressed anguish over the way things have transpired in the 2nd wave of COVID-19 where vaccine shortage is hitting everyone even when the Centre says the best way to fight the pandemic is to vaccinate everyone.

• 

  Stocks To Watch: Wipro, Persistent Systems, Panacea Biotec

  Wipro has sold its entire 33.33 per cent stake in Denim Group for a consideration of $22.42 million (about Rs 160 crore)

• 

  Panacea Biotec Soars 5% On Starting Sputnik V Manufacturing in India

  "The first batch produced at the company's facilities at Baddi will be shipped to the Gamaleya Center for quality control. Full-scale production of the vaccine is due to start this summer," Panacea Biotech said

• 

  Stocks To Watch:Grasim Industries,Panacea Biotec,SBI Cards

  Grasim Industries reported a 35.7 per cent rise in net profit at Rs 480.2 crore for the quarter ended March 2021 from Rs 353.8 crore in the same quarter last year

• 

  COVID-19 Vaccine Sputnik V Production Launched In India

  Domestic pharma major Panacea Biotec in collaboration with Russian sovereign wealth fund Russian Direct Investment Fund has begun the production of Sputnik V COVID-19 vaccine in India, according to a joint statement issued today.

• 

  India's Panacea Biotec To Make 100 Million Sputnik Vaccine Doses Yearly: Report

  Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.

• 

  Panacea Biotec To Partner With US-Based Refana Inc For COVID-19 Vaccine

  Biotech firm Panacea Biotec Ltd said on Wednesday it would partner with US-based Refana Inc to make a potential vaccine for COVID-19.

• 

  Narayana Hrudayalaya To Acquire Panacea Biotec Arm For Rs 180 Crore

  This transaction is intended to consolidate Narayana Hrudayalaya's footprint in the northern cluster.

• 

  Panacea Biotec Surges 7% As FDA Clears Solan Facility

  Shares of Panacea Biotec surged as much as 6.76 per cent to hit intraday high of Rs 112.80 in an otherwise weak market after the US drug regulator (USFDA) gave its Establishment Inspection Report (EIR) for the Indian drugmaker's facilities in Solan, Himachal Pradesh.

• 

  Panacea Biotec Launches Diabetes Drug

  Drug firm Panacea Biotec has launched diabetes drug 'Tenepan', used for treating Type 2 Diabetes Mellitus, in the country.

• Panacea Biotec posts net profit of Rs 83 crore in Q3

  Panacea Biotec on Thursday posted a net profit of Rs 82.79 crore for the third quarter that ended on December 31, 2013.

• Panacea to scale up anti-cancer production, starts new plant

  Drug firm Panacea Biotec said it is scaling up production of anti-cancer products with the commissioning of its new facility at Baddi in Himachal Pradesh set up at an investment of Rs 55 crore.

• PANACEA BIOTEC LTD. - Outcome of AGM

  Panacea Biotec Ltd has informed BSE that 27th Annual General Meeting (AGM) of the Company was held on September 24, 2011.